SCHEMBL6503817

SCHEMBL6503817

CSc1ccc(C=CC(=O)N2CCC(C(=O)NC(Cc3ccc(-c4ccc(Cl)cc4)cc3)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB2 P05107 5/20 0.47
ICAM1 P05362 5/20 0.47
ITGAL P20701 5/20 0.47
CAPN1 P07384 4/20 0.47
ENPP2 Q13822 2/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PSMB11 A5LHX3 1/20 0.38
PSMA7 O14818 1/20 0.38
PSMB1 P20618 1/20 0.38
PSMA1 P25786 1/20 0.38
PSMA2 P25787 1/20 0.38
PSMA3 P25788 1/20 0.38
PSMA4 P25789 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB9 P28065 1/20 0.38
PSMA5 P28066 1/20 0.38
PSMB4 P28070 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8298729 1.00 ITGB2 (0.47) ITGB2ICAM1ITGALCAPN1ENPP2
SCHEMBL6505573 0.96 CAPN1 (0.51) ITGB2ICAM1ITGALCAPN1MAPK1
SCHEMBL8296181 0.93 ITGB2 (0.46) ITGB2ICAM1ITGALCAPN1ENPP2
SCHEMBL6532600 0.93 ITGB2 (0.46) ITGB2ICAM1ITGALCAPN1ENPP2
SCHEMBL6534047 0.93 ITGB2 (0.46) ITGB2ICAM1ITGALCAPN1ENPP2
SCHEMBL6497576 0.92 ITGB2 (0.48) ITGB2ICAM1ITGALCAPN1MAPK1
SCHEMBL6497573 0.92 ITGB2 (0.48) ITGB2ICAM1ITGALCAPN1MAPK1
SCHEMBL8297323 0.92 CAPN1 (0.56) ITGB2ICAM1ITGALCAPN1MAPK1
SCHEMBL6506110 0.92 CAPN1 (0.56) ITGB2ICAM1ITGALCAPN1MAPK1
SCHEMBL6506117 0.92 CAPN1 (0.56) ITGB2ICAM1ITGALCAPN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed